Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin safety test of M118104 in healthy adults
jRCT2031240385Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of M118104 in Sebum deficiency and Greither Disease, sponsored by Maruho Co., Ltd. Primary endpoints: Skin safety and Overall safety. Started Oct 2024; status: completed.
02
Drugs
M118104
03
Conditions
Sebum deficiencyGreither Disease
Beyond the preview
Go deeper on jRCT2031240385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240385.